Literature DB >> 21330422

25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.

Anand Vaidya1, John P Forman, Paul N Hopkins, Ellen W Seely, Jonathan S Williams.   

Abstract

INTRODUCTION: Concentrations of 1,25-hydroxyvitamin D have been positively associated with dietary sodium and salt sensitivity (SS) of blood pressure (BP), and inversely with plasma renin activity (PRA). We investigated the association between PRA and 25-hydroxyvitamin D (25OHD), the most clinically relevant vitamin D metabolite, and whether 25OHD associates with SS of BP in renin phenotypes of hypertension.
METHODS: We performed cross-sectional analyses on 223 Caucasian subjects with hypertension maintained in high and low dietary sodium balance. Subjects were distinguished as having low-renin (LR) or normal-renin (NR) hypertension. Multivariable linear regression was used to evaluate adjusted relationships.
RESULTS: Increasing 25OHD concentrations were inversely associated with PRA (p < 0.05) on both salt diets. Furthermore, 25OHD was associated with SS of BP in LR hypertension (b = 0.62, p = 0.04), but not in NR hypertension (b = 0.06, p = 0.59). In an adjusted multivariable interaction model, renin status (LR vs. NR) was a significant effect modifier of the relationship between 25OHD and SS of BP (p = 0.04).
CONCLUSIONS: Our findings suggest that 25OHD is inversely associated with PRA and positively associated with SS of BP in LR hypertension subjects. These results extend and support prior evidence indicating an interaction between dietary sodium, the RAS, and vitamin D that influences BP in hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330422      PMCID: PMC3146958          DOI: 10.1177/1470320310391922

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  57 in total

1.  Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan.

Authors:  John P Forman; Deborah A Price; Radomir Stevanovic; Naomi Dl Fisher
Journal:  J Hypertens       Date:  2007-04       Impact factor: 4.844

2.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.

Authors:  John P Forman; Edward Giovannucci; Michelle D Holmes; Heike A Bischoff-Ferrari; Shelley S Tworoger; Walter C Willett; Gary C Curhan
Journal:  Hypertension       Date:  2007-03-19       Impact factor: 10.190

3.  Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.

Authors:  Yan Zhang; Dilip K Deb; Juan Kong; Gang Ning; Yurong Wang; George Li; Yunzi Chen; Zhongyi Zhang; Stephen Strugnell; Yves Sabbagh; Cynthia Arbeeny; Yan Chun Li
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

4.  Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Authors:  Emil Hagström; Per Hellman; Tobias E Larsson; Erik Ingelsson; Lars Berglund; Johan Sundström; Håkan Melhus; Claes Held; Lars Lind; Karl Michaëlsson; Johan Arnlöv
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

Review 5.  Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement.

Authors:  Duncan J Campbell; Juerg Nussberger; Michael Stowasser; A H Jan Danser; Alberto Morganti; Erik Frandsen; Joël Ménard
Journal:  Clin Chem       Date:  2009-03-05       Impact factor: 8.327

Review 6.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

Review 7.  The role of calcium in the regulation of renin secretion.

Authors:  William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-29

Review 8.  Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.

Authors:  Carolina R C Doorenbos; Jacob van den Born; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

9.  Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium.

Authors:  Juan Kong; Guilin Qiao; Zhongyi Zhang; Shu Q Liu; Yan Chun Li
Journal:  Kidney Int       Date:  2008-10-01       Impact factor: 10.612

Review 10.  Vitamin D status and arterial hypertension: a systematic review.

Authors:  Stefan Pilz; Andreas Tomaschitz; Eberhard Ritz; Thomas R Pieber
Journal:  Nat Rev Cardiol       Date:  2009-08-18       Impact factor: 32.419

View more
  44 in total

1.  Meta-Analysis of the Association Between the rs228570 Vitamin D Receptor Gene Polymorphism and Arterial Hypertension Risk.

Authors:  Ivone F O C Nunes; Ana A C M Cavalcante; Marcus V O B Alencar; Marcos D F Carvalho; José L R Sarmento; Nayra S C C A Teixeira; Adriana A Paiva; Lídia R Carvalho; Leopoldo F M Nascimento; Maria S P Cruz; Marcelo M Rogero; Andréia C B Lima; Cecilia M R G Carvalho
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

Review 2.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.

Authors:  Anand Vaidya; Jonathan S Williams
Journal:  Metabolism       Date:  2011-11-09       Impact factor: 8.694

3.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

Review 4.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

5.  The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension.

Authors:  Anand Vaidya; Luminita Pojoga; Patricia C Underwood; John P Forman; Paul N Hopkins; Gordon H Williams; Jonathan S Williams
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

6.  Vitamin D and cardio-metabolic disease.

Authors:  Anand Vaidya
Journal:  Metabolism       Date:  2013-09-16       Impact factor: 8.694

7.  Associations between Vitamin D and Cardiovascular Disease Risk Factors in African Americans Are Partly Explained by Circulating Adipokines and C-Reactive Protein: The Jackson Heart Study.

Authors:  Rumana J Khan; Samson Y Gebreab; Pia Riestra; Mario Sims; Amadou Gaye; Ruihua Xu; Sharon K Davis
Journal:  J Nutr       Date:  2016-10-26       Impact factor: 4.798

8.  Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.

Authors:  Q Cheng; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2012-12-19       Impact factor: 10.122

9.  Effect of vitamin D supplementation on blood pressure in blacks.

Authors:  John P Forman; Jamil B Scott; Kimmie Ng; Bettina F Drake; Elizabeth Gonzalez Suarez; Douglas L Hayden; Gary G Bennett; Paulette D Chandler; Bruce W Hollis; Karen M Emmons; Edward L Giovannucci; Charles S Fuchs; Andrew T Chan
Journal:  Hypertension       Date:  2013-04       Impact factor: 10.190

10.  Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.

Authors:  Jenifer M Brown; Jonathan S Williams; James M Luther; Rajesh Garg; Amanda E Garza; Luminita H Pojoga; Daniel T Ruan; Gordon H Williams; Gail K Adler; Anand Vaidya
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.